(Q47756541)

5 February 2018

title

Resolution of renal inflammation: a new role for NF-kappaB1 (p50) in inflammatory kidney diseases. (English)

1 reference

5 February 2018

0 references

Ulf Panzer

1

1 reference

5 February 2018

Oliver M Steinmetz

2

1 reference

5 February 2018

Jan-Eric Turner

3

1 reference

5 February 2018

Catherine Meyer-Schwesinger

4

1 reference

5 February 2018

Claudia von Ruffer

5

1 reference

5 February 2018

Tobias N Meyer

6

1 reference

5 February 2018

Gunther Zahner

7

1 reference

5 February 2018

Carmen Gómez-Guerrero

8

1 reference

5 February 2018

Roland M Schmid

9

1 reference

5 February 2018

Udo Helmchen

10

1 reference

5 February 2018

Gilbert W Moeckel

11

1 reference

5 February 2018

Gunter Wolf

12

1 reference

5 February 2018

Rolf A K Stahl

13

1 reference

5 February 2018

Friedrich Thaiss

14

1 reference

5 February 2018

publication date

20 May 2009

1 reference

5 February 2018

American Journal of Physiology - Renal Physiology

published in

1 reference

5 February 2018

volume

297

1 reference

5 February 2018

issue

2

1 reference

5 February 2018

page(s)

F429-39

1 reference

5 February 2018

Tumor necrosis factor alpha transcription in macrophages is attenuated by an autocrine factor that preferentially induces NF-kappaB p50.

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90435.2008

NF-kappaB1 (p50) homodimers differentially regulate pro- and anti-inflammatory cytokines in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90435.2008

Lipopolysaccharide signaling in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90435.2008

Renal Toll-like receptors: recent advances and implications for disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90435.2008

Inflammatory cells in renal injury and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90435.2008

Inflammatory resolution: new opportunities for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90435.2008

Transcription factor-kappa B (NF-kappa B) and renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90435.2008

In situ non-radioactive detection of nuclear factors in paraffin sections by Southwestern histochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90435.2008

Transcriptional regulation via the NF-kappaB signaling module.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90435.2008

Gliotoxin enhances radiotherapy via inhibition of radiation-induced GADD45a, p38, and NFkappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90435.2008

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90435.2008

Targeting leukocytes in immune glomerular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90435.2008

Multiple facets of macrophages in renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90435.2008

Possible new role for NF-kappaB in the resolution of inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90435.2008

Anti-inflammatory lipid mediators and insights into the resolution of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90435.2008

Nuclear factor-kappa B inhibitors as potential novel anti-inflammatory agents for the treatment of immune glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90435.2008

Rho kinase inhibition attenuates LPS-induced renal failure in mice in part by attenuation of NF-kappaB p65 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90435.2008

Nuclear factor-kappaB p50 limits inflammation and prevents lung injury during Escherichia coli pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90435.2008

Nuclear factor-kappaB1 (p50) limits the inflammatory and fibrogenic responses to chronic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90435.2008

Effects of different PPARgamma-agonists on MCP-1 expression and monocyte recruitment in experimental glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90435.2008

Differential activation of NF-kappa B, AP-1, and C/EBP in endotoxin-tolerant rats: mechanisms for in vivo regulation of glomerular RANTES/CCL5 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90435.2008

Induction of B7-1 in podocytes is associated with nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90435.2008

Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor kappaB response

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90435.2008

Roles of the mesangium in glomerular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90435.2008

Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90435.2008

Resolution of inflammation: state of the art, definitions and terms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90435.2008

Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90435.2008

Resolution of inflammation: the beginning programs the end

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90435.2008

NF-kappaB: a key role in inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90435.2008

Macrophages and the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90435.2008

Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis [seecomments]

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90435.2008

Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90435.2008

The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90435.2008

10.1152/AJPRENAL.90435.2008

21 January 2018

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

19458123

1 reference

5 February 2018